Rachael Easton
Financieel Directeur/CFO bij GLADSTONE INVESTMENT CORPORATION
Profiel
Rachael Easton is currently the Chief Financial Officer & Treasurer at Gladstone Investment Corp.
and the Vice President & Head-Clinical Development at Cogent Biosciences, Inc. She previously worked as the Sr. Medical Director-Oncology Clinical Development at GSK Plc.
Easton received her undergraduate degree from Washington & Lee University and her doctorate from Washington University School of Medicine.
Actieve functies van Rachael Easton
| Bedrijven | Functie | Begin |
|---|---|---|
| COGENT BIOSCIENCES, INC. | Hoofd Techniek/Wetenschap/O&O | 28-11-2022 |
| GLADSTONE INVESTMENT CORPORATION | Financieel Directeur/CFO | 01-12-2021 |
Eerdere bekende functies van Rachael Easton
| Bedrijven | Functie | Einde |
|---|---|---|
| GSK PLC | Corporate Officer/Principal | - |
Opleiding van Rachael Easton
| Washington University School of Medicine | Doctorate Degree |
| Washington & Lee University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| COGENT BIOSCIENCES, INC. | Health Technology |
| GSK PLC | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Gladstone Investment Corp.
 Gladstone Investment Corp. Investment ManagersFinance Gladstone Investment Corp., a traded business development company invests in lower middle market companies located in the United States. The fund focuses on companies with an EBITDA of $3 to $20 million. It targets companies operating in the fields of manufacturing, consumer products and business and consumer services. It provides financing for debt, buyout and growth stage capital requirements with an investment size up to $75 million.. | Finance |
